Abdel Kareem Azab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abdel Kareem Azab has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Jeske
Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA
1 shared publication - Ayah Khaskiah
Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit 627, West Bank, Palestine
1 shared publication - Berit Lubben
Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA
1 shared publication - Chaelee Park
Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, USA
1 shared publication - Hannah Bash
Thomas Jefferson University Hospital
1 shared publication - Jennifer Sun
Washington University in St. Louis
1 shared publication
Latest Publications
- Open Access
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
MM is the second most common hematological malignancy and represents approximately 20% of deaths from hematopoietic cancers. The advent of novel agents has changed the therapeutic landscape of MM treatment; however, MM remains incurable. T cell-based immunotherapy such as BTCEs is a promising modality for the treatment of MM. This review article discusses the advancements and future directions of BTCE treatments for MM.
Open AccessBispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
MM is the second most common hematological malignancy and represents approximately 20% of deaths from hematopoietic cancers. The advent of novel agents has changed the therapeutic landscape of MM treatment; however, MM remains incurable. T cell-based immunotherapy such as BTCEs is a promising modality for the treatment of MM. This review article discusses the advancements and future directions of BTCE treatments for MM.